Literature DB >> 31177468

A Low-Molecular-Weight Phenotype of Apolipoprotein(a) as a Factor Provoking Accumulation of Cholesterol by THP-1 Monocyte-Like Cells.

O I Afanas'eva1, E B Vikhrova2, O A Razova2, E A Utkina2, M I Afanas'eva2, E A Klesareva2, N V Radyukhina2, T I Aref'eva2, S N Pokrovsky2.   

Abstract

Increased concentration of lipoprotein(a) is a risk factor of coronary heart disease. lipoprotein(a) consists of LDL-like and highly polymorphic apolipoprotein(a). Here we studied the effect of lipoprotein(a)-containing sera with different apolipoprotein(a) phenotypes on lipid accumulation by THP-1 monocyte-like cells. Cholesterol concentration in lysates of THP-1 cells was significantly higher after their incubation with lipoprotein(a)-containing serum samples with low-molecular-weight phenotype of apolipoprotein(a) in comparison with samples with a high-molecular-weight apolipoprotein(a) phenotype irrespective of initial cholesterol level as well as serum concentrations of apoB-100, oxidized LDL, and circulating immune complexes. The presence of the most atherogenic small dense LDL subfractions in examined sera in addition to a low-molecular-weight apolipoprotein(a) phenotype resulted in significant elevation of cholesterol accumulation by THP-1 cells. The data obtained explain greater atherogenicity of lipoprotein(a) with low-molecular-weight apolipoprotein(a) phenotype.

Entities:  

Keywords:  THP-1 cells; apo(a) phenotype; lipoprotein subfractions; lipoprotein(a); macrophages

Mesh:

Substances:

Year:  2019        PMID: 31177468     DOI: 10.1007/s10517-019-04452-w

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  1 in total

1.  Low Molecular Weight Apolipoprotein(a) Phenotype Rather Than Lipoprotein(a) Is Associated With Coronary Atherosclerosis and Myocardial Infarction.

Authors:  Olga I Afanasieva; Marat V Ezhov; Narek A Tmoyan; Oksana A Razova; Marina I Afanasieva; Yuri G Matchin; Sergei N Pokrovsky
Journal:  Front Cardiovasc Med       Date:  2022-03-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.